Riskpilot← Back to searchSign inGet full accessStorvretens Vårdcentral AB
ABActiveOrg 5567341846Stenvägen 10General medical practice activities · NACE 8621Est. 200729 employees
Revenue 2024
SEK 34,9M
+4% vs 2023
EBITDA margin
10.3%
+256% vs 2023
Equity ratio
3.7%
Financial strength
Net profit 2024
SEK 88K
+144% vs 2023
| Revenue | SEK 34,9M | +4% |
| EBITDA | SEK 3,6M | +256% |
| Net profit | SEK 88K | +144% |
| Total assets | SEK 16,9M | +11% |
| Equity | SEK 621K | +17% |
| Employees | 29 | — |
Legal name
Storvretens Vårdcentral AB
Org number
5567341846
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
4 juli 2007
Share capital
SEK 100 000
Employees
29 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva hälso- och sjukvårdsverksamhet samt därmed förenlig verksamhet.
Address
Stenvägen 10
Phone
+46853067700
Email
stefan.amer@famlak.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 32 871 | 38 834 | 34 097 | 33 643 | 34 857 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −351 | 564 | 1 212 | 1 008 | 3 585 |
| Depreciation & amort. | −20 | −17 | −26 | −22 | −22 |
| EBIT | −371 | 547 | 1 186 | 986 | 3 563 |
| Net financials | −23 | −90 | 2 | −69 | −1 149 |
| Profit before tax | −394 | 456 | 35 | 68 | 413 |
| Tax | −0 | −0 | −25 | −32 | −325 |
| Net profit | −394 | 456 | 10 | 36 | 88 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 5 437 | 7 499 | 10 626 | 15 208 | 16 949 |
| Equity | 130 | 486 | 496 | 533 | 621 |
| Long-term debt | 0 | 0 | 0 | 10 805 | 11 955 |
| Short-term debt | 5 308 | 7 013 | 10 130 | 3 871 | 4 373 |
| Total debt | 5 308 | 7 013 | 10 130 | 14 676 | 16 328 |
EBITDA margin
10.3%
This company
15.8%
Market median
-35% vs market
20202024
Equity ratio
3.7%
This company
38.2%
Market median
-90% vs market
20202024
Return on equity
14.2%
This company
18.4%
Market median
+23% vs market
20202024
Net profit margin
0.3%
This company
8.1%
Market median
-96% vs market
20202024
Asset turnover
2.06×
This company
1.12×
Market median
+84% vs market
20202024
Debt / equity
26.29×
This company
0.62×
Market median
-4140% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
SE Chief Executive Officer | Chief Executive Officer | 2022 |
MS Audit | Audit | 2025 |
AM Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2025 |
| Former (1) | ||
NO Chief Executive Officer | Chief Executive Officer | 2021 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
| Deputy Board Member | 2021 – 2022 | |
| Chairman | 2021 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Familjeläkarna i Saltsjöbaden AB
Storvretens Vårdcentral AB Board members of Storvretens Vårdcentral AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Stefan Erik Ingvar Amér | Chief Executive Officer | 0 companies |
| Nils Olof Wikström | Chief Executive Officer | 0 companies |
| Mikael Stefan Köver | Audit | 0 companies |
| Anna Maria Cecilia Amér | Deputy Chief Executive Officer | 0 companies |
| Sofie Wikström | Deputy Board Member | 0 companies |
| Börje Lars-Olof Roos | Chairman | 0 companies |